Neurolens announced a major new update to its business operations: a new rebrand as an “innovation company” under the name Newton.
Let’s start with the company (before its rebrand).
Originally founded in 2012, the Coppell, Texas-headquartered medical device and healthcare technology company is most known for its development of prescription eyewear lenses and technology designed to:
- Compensate for patients' misalignments across all visual distances (near, intermediate, and far)
- Relieve symptoms associated with digital eye strain (including headaches, shoulder tension, and neck pain)
Most notably: The company’s Neurolenses are the world’s first and only therapeutic lenses that have been clinically proven to provide relief for headaches, motion sickness, and neck pain.
But more on that later.
Tell me about this rebrand.
The “innovation” company selected its new name as an homage to Sir Isaac Newton, whom it refers to as “one of history’s greatest innovators,” who laid the foundation for modern optics.
- Per Newton (the company): “This spirit of innovation is reflected in (our) mission to uncover new possibilities in vision care and challenge conventional standards in optometry.”
Focus on that eyecare component.
As CEO Davis Corley noted, the company’s new name represents more than a rebrand—“It signals the next chapter in transforming eye care beyond 20/20.”
The rebrand is targeting a redefinition of eye care through a few key actions:
- Continuing to support optometry practices
- Providing “exceptional” patient experiences and outcomes
- Breakthrough technologies
Nice! Now about these breakthrough technologies—any changes to know about?
The company’s rebrand won’t affect its already established lenses and technology. Which brings us to … the Neurolens system.
- What this is: A novel device and lens technology designed to objectively detect and relieve symptoms associated with eye misalignment with prescription-based contoured prism lenses.”
- Its purpose: To relieve eye misalignment symptoms and patients experiencing vision-related issues associated with digital eye strain and computer vision syndrome.
And what’s this technology you mentioned?
That would be the company’s patented Contoured Prism technology, a uniquely-designed prism embedded in the company’s lenses that offers gradual prism adjustment to:
- Ensure accurate (binocular) alignment across all viewing distance
- Avoid the rigidity of conventional prism correction
See here for details on how the lenses and technology work together to correct this eye alignment.
So how is this alignment measured?
Through the company's N3 measurement device (launched in 2023).
What it is: An immersive, virtual reality (VR)-based headset device that measures binocular alignment.
- See here for more details on this.
What else should we know about these lenses?
As we mentioned earlier, they’re clinically validated.
The basis for this: Research published last year that explored the impact and effectiveness of Neurolens in patients experiencing headaches caused by potential vision-related issues.
And in other research: An estimated 90% of patients experienced symptom relief related to eye misalignment (and over 80% have reported headache relief) following use of the Neurolens technology.
Plus, as the recent company noted, its lenses have helped hundreds of thousands of patients find the relief they'd been searching for—often within days of wearing their first pair of Neurolenses.
Impressive! So what can we expect from the newly-named Newton?
To start, the company hinted that ECPs can expect some new innovations later this month—so stay tuned for more info on that in the coming weeks!
Editor's note: This article was updated on Sept. 11, 2025.